News

The London-based company whose flagship platform uses artificial intelligence to supply transport corridor analytics said the contract will see it supply DG8 with two sets of its Wave 32 Rugged Lidar ...
(Alliance News) - Donald Trump is expected to arrive in the UK as his plane is scheduled to refuel at a US airbase. Flight restrictions around RAF Mildenhall in Suffolk indicate the US president's Air ...
Rolls-Royce Holdings PLC - London-based aerospace and defence engineering - Rob Watson, president of Civil Aerospace, sells 40,000 shares at GBP7.88, worth GBP315,040, on Thursday last week. Cairn ...
Shares in Dekel were trading 14% higher at 1.23 pence each at around midday on Monday.
Wages are still growing too fast for inflation to sustainably come down to the 2% target, said Clare Lombardelli, deputy governor for monetary policy. She also warned that global growth will be ...
(Alliance News) - SolGold PLC on Monday said it received an environmental licence for an advanced exploration phase at the Porvenir project in southern Ecuador's Zamora Chinchipe province. The licence ...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Likewise Group PLC - Birmingham, England-based ...
(Alliance News) - Alkemy Capital Investments PLC shares surged on Monday as it said it has entered an exclusivity agreement with private equity firm Ara Advisers LLC for a proposed investment in ...
Chief Executive Tom Clayton commented: "The financial year ended 31 March 2025 was a breakout year for IntelliAM. With ARR increasing by more than 400% H2 over H1 and pro-forma revenue up at ...
The Peru-focused oil and gas development company said average production rose 26% to 23,281 barrels of oil per day in the first quarter of 2025 from 18,518 barrels a year before. Oil revenue climbed 9 ...
The improvement came largely from a GBP1.2 million capital raise completed in March, which compensated for a decline in the value of Caledonian's investment portfolio. The raise included a placing, ...
The Derbyshire, England-based pharmaceutical company said the testing on mice evaluated the use of its Nuvec proof-of-concept programme, N4 101, which is an orally delivered anti-inflammatory ...